Modeling cancer in mice
- 5 August 2002
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 21 (35), 5504-5514
- https://doi.org/10.1038/sj.onc.1205603
Abstract
The laboratory mouse is one of the most powerful tools for both gene discovery and validation in cancer genetics. Recent technological advances in engineering the mouse genome with chromosome translocations, latent alleles, and tissue-specific and temporally regulated mutations have provided more exacting models of human disease. The marriage of mouse tumor models with rapidly evolving methods to profile genetic and epigenetic alterations in tumors, and to finely map genetic modifier loci, will continue to provide insight into the key pathways leading to tumorigenesis. These discoveries hold great promise for identifying relevant drug targets for treating human cancer.Keywords
This publication has 85 references indexed in Scilit:
- DNMT1 and DNMT3b cooperate to silence genes in human cancer cellsNature, 2002
- Conditional control of gene expression in the mouseNature Reviews Genetics, 2001
- Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBFNature, 2001
- Genome-Wide Location and Function of DNA Binding ProteinsScience, 2000
- Aberrant CpG-island methylation has non-random and tumour-type–specific patternsNature Genetics, 2000
- The Hallmarks of CancerCell, 2000
- Ecdysone-inducible gene expression in mammalian cells and transgenic mice.Proceedings of the National Academy of Sciences, 1996
- Effects of an Rb mutation in the mouseNature, 1992
- Targeted mutation of the DNA methyltransferase gene results in embryonic lethalityCell, 1992
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985